NCT05584982View on ClinicalTrials.gov

Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 12, 2022

Study Completion Date

October 12, 2022

Conditions
Cystic FibrosisLung Infection Bacterial
Interventions
DEVICE

AtbFinder

In the present study, we provided a prospective evaluation of the effectiveness of antibiotics selected with AtbFinder compared to a retrospective analysis of antibiotic efficacy selected with conventional culture-based antibiotic susceptibility tets in patients with cystic fibrosis

All Listed Sponsors
lead

TGV-Dx

INDUSTRY

NCT05584982 - Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic Fibrosis | Biotech Hunter | Biotech Hunter